Literature DB >> 32921631

Emerging roles of the MAGE protein family in stress response pathways.

Rebecca R Florke Gee1,2, Helen Chen1, Anna K Lee1, Christina A Daly1,2, Benjamin A Wilander1,2, Klementina Fon Tacer3,4, Patrick Ryan Potts3.   

Abstract

The melanoma antigen (MAGE) proteins all contain a MAGE homology domain. MAGE genes are conserved in all eukaryotes and have expanded from a single gene in lower eukaryotes to ∼40 genes in humans and mice. Whereas some MAGEs are ubiquitously expressed in tissues, others are expressed in only germ cells with aberrant reactivation in multiple cancers. Much of the initial research on MAGEs focused on exploiting their antigenicity and restricted expression pattern to target them with cancer immunotherapy. Beyond their potential clinical application and role in tumorigenesis, recent studies have shown that MAGE proteins regulate diverse cellular and developmental pathways, implicating them in many diseases besides cancer, including lung, renal, and neurodevelopmental disorders. At the molecular level, many MAGEs bind to E3 RING ubiquitin ligases and, thus, regulate their substrate specificity, ligase activity, and subcellular localization. On a broader scale, the MAGE genes likely expanded in eutherian mammals to protect the germline from environmental stress and aid in stress adaptation, and this stress tolerance may explain why many cancers aberrantly express MAGEs Here, we present an updated, comprehensive review on the MAGE family that highlights general characteristics, emphasizes recent comparative studies in mice, and describes the diverse functions exerted by individual MAGEs.
© 2020 Florke Gee et al.

Entities:  

Keywords:  AMP-activated kinase (AMPK); DNA damage response; E3 ligase; E3 ubiquitin ligase; Fe-S cluster; MAGE; Prader-Willi syndrome; Schaaf-Yang syndrome; alternative polyadenylation; apoptosis; cancer; cancer-testis antigen; cell metabolism; melanoma antigen; metabolism; p53; spermatogenesis; stress adaptation; stress granule; stress response; ubiquitin; ubiquitination

Year:  2020        PMID: 32921631      PMCID: PMC7681028          DOI: 10.1074/jbc.REV120.008029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  410 in total

Review 1.  Regulation of androgen action during establishment of pregnancy.

Authors:  Douglas A Gibson; Ioannis Simitsidellis; Philippa T K Saunders
Journal:  J Mol Endocrinol       Date:  2016-04-11       Impact factor: 5.098

2.  Cancer-testis antigen HCA587/MAGE-C2 interacts with BS69 and promotes its degradation in the ubiquitin-proteasome pathway.

Authors:  Jiaqing Hao; Rui Shen; Yan Li; Yu Zhang; Yanhui Yin
Journal:  Biochem Biophys Res Commun       Date:  2014-05-24       Impact factor: 3.575

Review 3.  Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis.

Authors:  S S Molloy; E D Anderson; F Jean; G Thomas
Journal:  Trends Cell Biol       Date:  1999-01       Impact factor: 20.808

4.  A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells.

Authors:  S Lucas; F Brasseur; T Boon
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

5.  MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.

Authors:  Brigitte Dreno; John F Thompson; Bernard Mark Smithers; Mario Santinami; Thomas Jouary; Ralf Gutzmer; Evgeny Levchenko; Piotr Rutkowski; Jean-Jacques Grob; Sergii Korovin; Kamil Drucis; Florent Grange; Laurent Machet; Peter Hersey; Ivana Krajsova; Alessandro Testori; Robert Conry; Bernard Guillot; Wim H J Kruit; Lev Demidov; John A Thompson; Igor Bondarenko; Jaroslaw Jaroszek; Susana Puig; Gabriela Cinat; Axel Hauschild; Jelle J Goeman; Hans C van Houwelingen; Fernando Ulloa-Montoya; Andrea Callegaro; Benjamin Dizier; Bart Spiessens; Muriel Debois; Vincent G Brichard; Jamila Louahed; Patrick Therasse; Channa Debruyne; John M Kirkwood
Journal:  Lancet Oncol       Date:  2018-06-13       Impact factor: 41.316

Review 6.  GSK's antigen-specific cancer immunotherapy programme: pilot results leading to Phase III clinical development.

Authors:  Vincent G Brichard; Diane Lejeune
Journal:  Vaccine       Date:  2007-09-27       Impact factor: 3.641

7.  Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.

Authors:  Qian Zhao; Wen-Ting Xu; Tuluhong Shalieer
Journal:  Dis Markers       Date:  2016-10-24       Impact factor: 3.434

8.  Ubiquitin Ligase Huwe1 Modulates Spermatogenesis by Regulating Spermatogonial Differentiation and Entry into Meiosis.

Authors:  Rohini Bose; Kai Sheng; Adel R Moawad; Gurpreet Manku; Cristian O'Flaherty; Teruko Taketo; Martine Culty; Kin Lam Fok; Simon S Wing
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

9.  CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.

Authors:  Chioniso P Masamha; Zheng Xia; Jingxuan Yang; Todd R Albrecht; Min Li; Ann-Bin Shyu; Wei Li; Eric J Wagner
Journal:  Nature       Date:  2014-05-11       Impact factor: 49.962

10.  A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis.

Authors:  Yanzhe Gao; Elizabeth Mutter-Rottmayer; Alicia M Greenwalt; Dennis Goldfarb; Feng Yan; Yang Yang; Raquel C Martinez-Chacin; Kenneth H Pearce; Satoshi Tateishi; Michael B Major; Cyrus Vaziri
Journal:  Nat Commun       Date:  2016-07-05       Impact factor: 14.919

View more
  13 in total

1.  PRAMEF2-mediated dynamic regulation of YAP signaling promotes tumorigenesis.

Authors:  Madhurima Ghosh; Sanjeev Das
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-30       Impact factor: 11.205

2.  Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Tomohiko Ito; Naohiro Oka; Ryosuke Kakinoki; Masao Akagi
Journal:  Eur J Histochem       Date:  2022-06-23       Impact factor: 1.966

3.  Chromosome-specific retention of cancer-associated DNA hypermethylation following pharmacological inhibition of DNMT1.

Authors:  Ashley K Wiseman; Rochelle L Tiedemann; Huihui Fan; Hui Shen; Zachary Madaj; Michael T McCabe; Melissa B Pappalardi; Peter A Jones
Journal:  Commun Biol       Date:  2022-06-02

Review 4.  Pathophysiological aspects of the thick ascending limb and novel genetic defects: HELIX syndrome and transient antenatal Bartter syndrome.

Authors:  Rosa Vargas-Poussou
Journal:  Pediatr Nephrol       Date:  2021-03-17       Impact factor: 3.651

5.  MAGEH1 interacts with GADD45G and induces renal tubular cell apoptosis.

Authors:  Gyu-Tae Shin; Ji Eun Park; Min-Jeong Lee
Journal:  PLoS One       Date:  2021-11-17       Impact factor: 3.240

6.  Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers.

Authors:  James Ellegate; Michalis Mastri; Emily Isenhart; John J Krolewski; Gurkamal Chatta; Eric Kauffman; Melissa Moffitt; Kevin H Eng
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

7.  MAGE genes encoding for embryonic development in cattle is mainly regulated by zinc finger transcription factor family and slightly by CpG Islands.

Authors:  Bosenu Abera; Hunduma Dinka
Journal:  BMC Genom Data       Date:  2022-03-18

8.  Expression and Prognostic Value of Melanoma-Associated Antigen D2 in Gliomas.

Authors:  Jun Yan; Shenyu Li; Cameron Lenahan; Hainan Chen; Jing Wen; Qianrong Huang; Qian Jiang; Fangzhou Guo; Teng Deng; Ligen Mo
Journal:  Brain Sci       Date:  2022-07-26

Review 9.  Increasing Role of Targeted Immunotherapies in the Treatment of AML.

Authors:  Jochen Greiner; Marlies Götz; Verena Wais
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

Review 10.  Necdin: A purposive integrator of molecular interaction networks for mammalian neuron vitality.

Authors:  Kazuaki Yoshikawa
Journal:  Genes Cells       Date:  2021-08-02       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.